BioCentury
ARTICLE | Emerging Company Profile

Cell Mogrify directly reprograms cells in vivo

How Cell Mogrify bypasses iPS cells to reprogram cells directly

April 25, 2019 10:58 PM UTC

Mogrify is jumping ahead of the technologies that have propelled the stem cell field by creating a platform that bypasses intermediate steps, and opens the door to in vivo reprogramming.

Cell Mogrify Ltd. uses small molecules and transcription factors to directly convert one mature cell type to another without first reverting through a pluripotent state, allowing it to avoid the problems of induced pluripotent stem (iPS) cells. ...

BCIQ Company Profiles

Mogrify Ltd.